BlackRock
FTH

BlackRock’s Faeth Therapeutics FTH Stock Holding History

BlackRock’s Portfolio FTH Stock Details FTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-389
Closed -$4.82K – 5310
2024
Q2 		$4.82K Sell
389
-1,290
-77% -$26.8K ﹤0.01% 5128
2024
Q1 		$35.3K Sell
1,679
-62
-4% -$1.07K ﹤0.01% 4942
2023
Q4 		$24.1K Sell
1,741
-20
-1% -$273 ﹤0.01% 5063
2023
Q3 		$28.2K Sell
1,761
-72
-4% -$1.55K ﹤0.01% 5095
2023
Q2 		$41.8K Sell
1,833
-72
-4% -$2.11K ﹤0.01% 5095
2023
Q1 		$57.2K Buy
1,905
+61
+3% +$1.81K ﹤0.01% 5094
2022
Q4 		$54.9K Sell
1,844
-6,854
-79% -$202K ﹤0.01% 5202
2022
Q3 		$270K Sell
8,698
-247
-3% -$9.71K ﹤0.01% 4895
2022
Q2 		$406K Sell
8,945
-49,456
-85% -$1.85M ﹤0.01% 4840
2022
Q1 		$2.7M Sell
58,401
-1,735
-3% -$138K ﹤0.01% 4269
2021
Q4 		$6.97M Buy
60,136
+10,120
+20% +$1.51M ﹤0.01% 3854
2021
Q3 		$10.5M Buy
50,016
+31,843
+175% +$5.8M ﹤0.01% 3649
2021
Q2 		$3.55M Buy
18,173
+1,538
+9% +$380K ﹤0.01% 4024
2021
Q1 		$4.83M Buy
+16,635
New +$5.57M ﹤0.01% 3956

Other funds holding FTH

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock's FTH Position: Q3 2024 in Review

BlackRock sold out of Faeth Therapeutics (FTH) in Q3 2024, closing a stake of 389 shares — an estimated $4.82K sold.

BlackRock first reported a position in FTH in Q1 2021 and held it in 14 quarters. The position peaked at $10.5M in Q3 2021. 19 funds tracked by Wall St. Rank hold FTH as of Q3 2024.

  • BlackRock reported no remaining Faeth Therapeutics position as of Q3 2024 after selling out during the quarter.
  • BlackRock sold 389 Faeth Therapeutics shares in Q3 2024, an estimated $4.82K.
  • BlackRock first reported a position in Faeth Therapeutics in Q1 2021 and held it in 14 quarters.
  • BlackRock's Faeth Therapeutics position peaked at $10.5M in Q3 2021.
  • 19 funds tracked by Wall St. Rank held Faeth Therapeutics as of Q3 2024.

Based on BlackRock's 13F filing for Q3 2024, filed 13 Nov 2024.